HALB News and Press, Tykhe Corp From 11/01/21

Elevated levels of IL-6 are believed to be causal factors in PTSD, Chronic Traumatic Encephalopathy, & Alzheimer's Disease. JACKSON CENTER, PA / ACCESSWIRE / November 1, 2021 / Halberd Corporation (OTC PINK:HALB) successfully eradicated 100% of IL-6 from synthetic cerebral spinal ...

JACKSON CENTER, PA / ACCESSWIRE / October 25, 2021 / Halberd Corporation (OTC PINK:HALB) announces the filing of a provisional patent application with the US Patent and Trademark Office covering their extracorporeal removal from the blood of patients of the various proteins, cytokines and ...

JACKSON CENTER, PA / ACCESSWIRE / October 20, 2021 / Halberd Corporation's (OTC PINK:HALB) ongoing research into discovering treatments/cures for PTSD, Alzheimer's Disease, and other neurodegenerative diseases has led to a potential breakthrough in the battle against obesity. Research has ...

GTX and Halberd will begin collaborating on developing and testing treatments for Alzheimer's Disease/PTSD and other neurological diseases and GTX will begin marketing Halberd's VitaShieldMax(TM) Immune Support through their online ecommerce platform Jackson Center, Pennsylvania--(Newsfile Co...

GTX and Halberd will begin collaborating on developing and testing treatments for Alzheimer's Disease/PTSD and other neurological diseases and GTX will begin marketing Halberd's VitaShieldMax TM Immune Support through their online ecommerce platform. JACKSON CENTER, PA / ACCESSWIRE / Oc...

Jackson Center, Pennsylvania--(Newsfile Corp. - October 5, 2021) - Halberd Corporation (OTC Pink: HALB) announced that its nutraceutical immune support product, VitaShieldMax TM , is now available through Amazon , in addition to its availability through Halberd's website at www.vitashieldmax...

Agreement To Advance Healthcare Diagnostic Technologies JACKSON CENTER, PA / ACCESSWIRE / September 22, 2021 / Halberd Corp. (OTC PINK:HALB) and heliosDx, a wholly owned company of RushNet, Inc. (OTC PINK:RSHN), an Alpharetta, GA company, announce a Scientific Collaboration Agreement ...

JACKSON CENTER, PA / ACCESSWIRE / September 13, 2021 / Halberd Corporation (OTC PINK:HALB) has successfully eradicated the primary building block of neurofibrillary tangles of Alzheimer's Disease from test fluids in laboratory testing. Through its patented extracorporeal process in combina...

JACKSON CENTER, PA / ACCESSWIRE / September 8, 2021 / Halberd Corporation (OTC PINK:HALB) announced the appointment of Anthony Mirabelli to the position of Vice-President, Mergers & Acquisitions. Mirabelli will be responsible for negotiating joint ventures, license agreements and other...

JACKSON CENTER, PA / ACCESSWIRE / August 30, 2021 / Halberd Corp. (OTC PINK:HALB) provided an update on its Alzheimer's Disease eradication experimentation being conducted at Youngstown State University (YSU) and Arizona State University (ASU). Following standard scientific methodology, Ha...